Artist's impression of virus cells within the human body

NHS England issues £755m framework for monoclonal antibodies

With a view to establishing a pharmaceutical medicines framework for monoclonal antibodies – a type of antibody treatment – NHS England has published a new £755m contract notice, with suppliers invited to bid.

Primarily based out the Midlands and East, the NHS England framework has four lots covering the supply of a number of key pharmaceutical products, including annual tranche, cytokine modulators, other monoclonal antibodies interleukin inhibitors, JAK inhibitors and medicines for migraine and asthma.

Alongside the primary lots supplying these branded medicines in the Midlands and East, there are also smaller lots listed on the contract notice to supply into pan-London regions and the South of England.

The one-year framework, with includes an optional extension of up to 24 months, is intended to launch in March 2021.

Monoclonal antibodies are potent, laboratory-made antibodies and have surfaced in the general media recently as a potential Covid-19 treatment, with the United States President Donald Trump having reportedly received treatment using them during his stay in hospital with the virus.

Significant funding for potential monoclonal antibody treatments have since been made available by health authorities in the United States.

In the UK, meanwhile, the first trials of monoclonal antibodies to help treat Covid-19 patients in UK hospitals were announced in mid-September, with the first treatments intended to begin in the coming weeks.

Those trials in UK hospitals will form part of the UK Recovery Trial.

NHE July/August 21

NHE July/August 21

Prioritising staff wellbeing

NHE’s July/August 2021 edition focuses on some of the key, defining aspects of a successful, supported health service: Mental Health & Workforce. Elsewhere, we take on the incredibly topical Infection Prevention and address the role which Pharma will play in both our NHS and wider health environment.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Net-Zero NHS

As was outlined by Sir Simon Stevens when the NHS announced their green plans back in 2020, 5,700 lives could be saved each year by improved air quality. Even more could see their overall health improve and be in a position to self-manage their conditions, rather than requiring NHS treatment. Covid-19 has already left the NHS with a sizeable treatment backlog, so anything which can be done to improve patient health and reduce demand is beneficial for all.

Working together, we can help the NHS realise its green ambitions as per the Net-Zero National Health Service report and its ambitious 2040 target. Join us on August 25, 2021 for our Net-Zero NHS event, where we will be joined by health sector leaders and innovators for a day of sharing best practice and networking.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all